His primary scientific interests are in Internal medicine, Immunology, Gastroenterology, Viral disease and Virology. His Internal medicine research includes themes of Nevirapine, Endocrinology, Efavirenz and Surgery. His research combines Acquired immunodeficiency syndrome and Immunology.
His biological study spans a wide range of topics, including Pharmacokinetics, Atazanavir, Pegylated interferon, Ribavirin and Stavudine. In his research, Complication and Hiv infected patients is intimately related to Immunopathology, which falls under the overarching field of Viral disease. His research investigates the link between Virology and topics such as Genotype that cross with problems in Concordance, HIV tropism and Tropism.
Juan González-Lahoz spends much of his time researching Virology, Immunology, Internal medicine, Acquired immunodeficiency syndrome and Gastroenterology. He regularly ties together related areas like Drug resistance in his Virology studies. His research in Viral disease, Hepatitis C virus, Lentivirus, CD8 and T cell are components of Immunology.
His research in Internal medicine intersects with topics in Didanosine and Sida. His Acquired immunodeficiency syndrome research is multidisciplinary, incorporating perspectives in Pharmacotherapy and Tuberculosis. The concepts of his Gastroenterology study are interwoven with issues in Nevirapine and Atazanavir.
His scientific interests lie mostly in Internal medicine, Immunology, Virology, Gastroenterology and Acquired immunodeficiency syndrome. His work carried out in the field of Internal medicine brings together such families of science as Lamivudine, Efavirenz, Viral load and Drug resistance. His work in the fields of Immunology, such as Hepatitis C virus, T cell, Immune system and Hepatitis B, overlaps with other areas such as CD38.
His study in Gastroenterology is interdisciplinary in nature, drawing from both Odds ratio and Atazanavir. His Acquired immunodeficiency syndrome study incorporates themes from Disease progression, Logistic regression and Pharmacotherapy. His studies in Logistic regression integrate themes in fields like Malignancy, microRNA, Circulating MicroRNA and Case-control study.
Internal medicine, Immunology, Virology, Gastroenterology and Acquired immunodeficiency syndrome are his primary areas of study. The study incorporates disciplines such as Efavirenz, Surgery and Drug in addition to Internal medicine. Immunology is often connected to microRNA in his work.
His Gastroenterology research integrates issues from Didanosine, Hepatitis C and Atazanavir. His work deals with themes such as Viral disease, Disease progression and Drug resistance, which intersect with Acquired immunodeficiency syndrome. As part of the same scientific family, Juan González-Lahoz usually focuses on Viral disease, concentrating on Viral load and intersecting with Lentivirus.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study
Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka.
PLOS ONE (2015)
Sociodemographic and psychological variables influencing adherence to antiretroviral therapy.
V Gordillo;J del Amo;V Soriano;J González-Lahoz.
Tuberculous Meningitis in Patients Infected with the Human Immunodeficiency Virus
Juan Berenguer;Santiago Moreno;Fernando Laguna;Teresa Vicente.
The New England Journal of Medicine (1992)
Increasing impact of chronic viral hepatitis on hospital admissions and mortality among HIV-infected patients.
Luz Martín-Carbonero;Vincent Soriano;Eulalia Valencia;Javier García-Samaniego.
AIDS Research and Human Retroviruses (2001)
Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter
David A. Cooper;Jose M. Gatell;Susanne Kroon;Nathan Clumeck.
The New England Journal of Medicine (1993)
A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients.
Remko Van Leeuwen;Christine Katlama;Robert Murphy;Kathleen Squires.
Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users
V. Soriano;J. García-samaniego;E. Valencia;R. Rodríguez-rosado.
European Journal of Epidemiology (1999)
Influence of 516G>T polymorphisms at the gene encoding the CYP450-2B6 isoenzyme on efavirenz plasma concentrations in HIV-infected subjects.
Sonia Rodriguez-Novoa;Pablo Barreiro;Ana Rendón;Inmaculada Jiménez-Nacher.
Clinical Infectious Diseases (2005)
Interferon α for the Treatment of Chronic Hepatitis C in Patients Infected with Human Immunodeficiency Virus
V Soriano;J García-Samaniego;R Bravo;J González.
Clinical Infectious Diseases (1996)
Risks and benefits of replacing protease inhibitors by nevirapine in HIV-infected subjects under long-term successful triple combination therapy.
P. Barreiro;V. Soriano;F. Blanco;C. Casimiro.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: